Bioactive Peptide Market
- 2026 年市場規模
- USD 7,089.6 Mn
- 2033 年預估規模
- USD 13,328.0 Mn
- 年複合成長率 CAGR
- 9.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Bioactive Peptide Market, By Source (Plant, Milk, Egg, Meat, Fish, Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)), By Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, Others (Gastrointestinal System and Cardiovascular System)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Drug Store and Mail-Order Pharmacy)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly. The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.
Market Dynamics
Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.
Similarly, in June 2021, Oryn Therapeutics, a clinical stage biotechnology company, had opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial, which was a Randomized, Double-blind, Vehicle Controlled, and Repeat Dose Comparative Study in RA (rheumatoid arthritis) Patients Managed with DMARDs (Disease-modifying antirheumatic drugs), whereas the Phase 1a clinical trial study had been successfully completed in 2020.
Key features of the study
• This report provides in-depth analysis of the global bioactive peptide market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 – 2030, considering 2021 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global bioactive peptide market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global bioactive peptide market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bioactive peptide market
Market Segmentation
• By Source
o Plant
o Milk
o Egg
o Meat
o Fish
o Others (Bacterial Antimicrobial Peptides, Venom Peptidomics)
• By Therapeutic Area
o Antihypertensive
o Antioxidant
o Immunostimulatory
o Antimicrobial
o Diabetes
o Others (Gastrointestinal System, Cardiovascular System)
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Others (Drug Store, Mail-Order Pharmacy)
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Archer Daniels Midland Company
o Seagarden AS
o Phermpep Co. Ltd.
o Arlak Biotech Pvt. Ltd.
o Naturade
o Royal DSM
o MYOS RENS Technology Inc.
o Natural Factors Inc.
o Valio Oy, GenScript
o HELIX BIOMEDIX
o Oryn Therapeutics
o Selecta Biosciences
o NIBEC
o Vivitide
o PEPTIDE INSTITUTE, INC
o BCN Peptides
o Setlance srl.
o APEPTICO Forschung und Entwicklung GmbH
o BIONANOPLUS
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
Market Snapshot, By Source
Market Snapshot, By Therapeutic Area
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Key Development
o Regulatory Scenario
o Reimbursement Scenario
o Pest Analysis
o Market Potential in Lower economies
4. Global Bioactive Peptide Market, By Source, 2026 – 2033, (US$ Million)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Plant
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Milk
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Egg
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Meat
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Fish
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
5. Global Bioactive Peptide Market, By Therapeutic Area, 2026 – 2033, (US$ Million)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026– 2033
Segment Trends
o Antihypertensive
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Antioxidant
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Immunostimulatory
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Antimicrobial
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Diabetes
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Others (Gastrointestinal System and Cardiovascular System)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
6. Global Bioactive Peptide Market, By Distribution Channel, 2026 – 2033, (US$ Million)
o Overview
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
o Others (Drug Store and Mail-Order Pharmacy)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (US$ Million)
7. Global Bioactive Peptide Market, By Region, 2026 – 2033, (US$ Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (US$ Million)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (US$ Million)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profile
Archer Daniels Midland Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Seagarden AS
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Phermpep Co. Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Arlak Biotech Pvt. Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Naturade
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Royal DSM
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
MYOS RENS Technology Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Natural Factors Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Valio Oy
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GenScript
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
HELIX BIOMEDIX
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Oryn Therapeutics
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Selecta Biosciences
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
NIBEC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
vivitide
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
PEPTIDE INSTITUTE, INC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
BCN Peptides
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Setlance srl.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
APEPTICO Forschung und Entwicklung GmbH
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
BIONANOPLUS
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們